BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36197268)

  • 21. Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas.
    Zhang C; Yao C; Li H; Wang G; He X
    Int J Mol Sci; 2014 Apr; 15(4):6544-55. PubMed ID: 24747591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks.
    Yang Z; Liu T; Ren X; Yang M; Tu C; Li Z
    Cell Cycle; 2022 Oct; 21(20):2121-2131. PubMed ID: 35699451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q; Song S; Ni G; Li Y; Wang X
    Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Serum miR-337-3p, miR-484, miR-582, and miR-3677 as Promising Biomarkers for Osteosarcoma.
    Luo H; Ye Z
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene.
    Pu Y; Zhao F; Wang H; Cai S
    Sci Rep; 2017 Mar; 7():44218. PubMed ID: 28281638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.
    Xu SH; Yang YL; Han SM; Wu ZH
    World J Surg Oncol; 2014 Jun; 12():195. PubMed ID: 24969351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
    Nakatani F; Ferracin M; Manara MC; Ventura S; Del Monaco V; Ferrari S; Alberghini M; Grilli A; Knuutila S; Schaefer KL; Mattia G; Negrini M; Picci P; Serra M; Scotlandi K
    J Pathol; 2012 Apr; 226(5):796-805. PubMed ID: 21960059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
    Li X; Yang H; Tian Q; Liu Y; Weng Y
    Neoplasma; 2014; 61(4):453-60. PubMed ID: 24645838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma.
    Li Y; Zhao C; Yu Z; Chen J; She X; Li P; Liu C; Zhang Y; Feng J; Fu H; Wang B; Kuang L; Li L; Lv G; Wu M
    Oncotarget; 2016 Oct; 7(42):68585-68596. PubMed ID: 27612424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-99b predicts clinical outcome of osteosarcoma and suppresses tumor cell proliferation, migration and invasion.
    Shi X; Guan X
    Diagn Pathol; 2019 Oct; 14(1):117. PubMed ID: 31651329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Noncoding MT1JP Enhanced the Inhibitory Effects of miR-646 on FGF2 in Osteosarcoma.
    Yang L; Liu G; Xiao S; Wang L; Liu X; Tan Q; Li Z
    Cancer Biother Radiopharm; 2020 Jun; 35(5):371-376. PubMed ID: 32196384
    [No Abstract]   [Full Text] [Related]  

  • 35. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma.
    Lian D; Wang ZZ; Liu NS
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1258-62. PubMed ID: 27097944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
    Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y
    J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer.
    Zeng Z; Chen X; Zhu D; Luo Z; Yang M
    Yonsei Med J; 2017 Jul; 58(4):697-702. PubMed ID: 28540980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma by targeting cyclin-dependent kinase, CDK6.
    Li Y; Liu J; Liu ZZ; Wei WB
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5117-5125. PubMed ID: 28051259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy.
    Hui WT; Ma XB; Zan Y; Wang XJ; Dong L
    Chin Med J (Engl); 2015 Oct; 128(19):2632-7. PubMed ID: 26415802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-429 and MiR-143-3p Function as Diagnostic and Prognostic Markers for Osteosarcoma.
    Yang L; Li H; Huang A
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.